Stay updated on GVAX & Pembrolizumab in MMR-p CRC Clinical Trial

Sign up to get notified when there's something new on the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new drug information related to Pembrolizumab and various cancer-related topics, while removing extensive details about other drugs and location specifics.
    Difference
    5%
    Check dated 2025-08-31T12:17:38.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T04:37:44.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-10T00:31:43.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    1%
    Check dated 2025-08-01T18:56:02.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.
    Difference
    0.2%
    Check dated 2025-07-25T13:57:59.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.5 to version 2.16.6.
    Difference
    0.1%
    Check dated 2025-07-18T10:57:40.000Z thumbnail image

Stay in the know with updates to GVAX & Pembrolizumab in MMR-p CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page.